MedPath

MASSACHUSETTS EYE AND EAR INFIRMARY

🇺🇸United States
Ownership
-
Established
1824-01-01
Employees
-
Market Cap
-
Website
http://www.masseyeandear.org/

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis

Phase 4
Completed
Conditions
Posterior Blepharitis
Meibomian Gland Dysfunction
Interventions
Drug: B+L Advanced Eye Relief Lubricant Drop
Drug: Loteprednol/tobramycin
Drug: Loteprednol
First Posted Date
2011-10-21
Last Posted Date
2017-08-01
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
60
Registration Number
NCT01456780
Locations
🇺🇸

Massachusetts Eye & Ear Infirmary, Boston, Massachusetts, United States

Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy

Not Applicable
Completed
Conditions
Post-operative Hemorrhage
Interventions
First Posted Date
2011-08-12
Last Posted Date
2017-07-12
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
314
Registration Number
NCT01415583
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

The Effects of Caffeinated Coffee on Intraocular Pressure

Not Applicable
Completed
Conditions
Primary Open Angle Glaucoma
Interventions
Other: Caffeinated Coffee
Other: Decaffeinated Coffee
First Posted Date
2011-06-02
Last Posted Date
2012-10-31
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
112
Registration Number
NCT01364207
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Effects of Anti-Glaucoma Medications on the Ocular Surface

Phase 4
Terminated
Conditions
Glaucoma
Interventions
First Posted Date
2011-03-15
Last Posted Date
2017-03-16
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
14
Registration Number
NCT01315574
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Not Applicable
Withdrawn
Conditions
Punctate Inner Choroidopathy (PIC)
Trauma, or Hereditary Eye Diseases
Angioid Streaks
Central Serous Chorioretinopathy (CSC)
Choroidal Neovascularization
Myopia
Multifocal Choroiditis
Ocular Histoplasmosis Syndrome
Interventions
Drug: Bevacizumab (Avastin; Genentech, Inc.)
Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
First Posted Date
2010-12-08
Last Posted Date
2014-01-14
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Registration Number
NCT01256580

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Phase 1
Withdrawn
Conditions
Stevens-Johnson Syndrome
Corneal Blindness
Interventions
First Posted Date
2010-12-08
Last Posted Date
2015-11-04
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Registration Number
NCT01256489
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Randomized Controlled Trial of Voice on Children With Vocal Nodules

Completed
Conditions
Vocal Fold Nodules
First Posted Date
2010-12-07
Last Posted Date
2016-12-02
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
114
Registration Number
NCT01255735
Locations
🇺🇸

Drexell University College of Medicine, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

🇨🇦

The Hospital For Sick Children, Toronto, Ontario, Canada

and more 1 locations

Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface

Phase 4
Completed
Conditions
Myopia
Refractive Error
Interventions
Drug: OPTI-FREE® RepleniSH®
Drug: Clear Care®
Drug: ReNu MultiPlus® MultiPurpose Solution
First Posted Date
2010-12-01
Last Posted Date
2017-01-10
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
94
Registration Number
NCT01250925
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations

Completed
Conditions
Normal Individuals With Visual Aberrations
First Posted Date
2010-10-28
Last Posted Date
2011-12-21
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
21
Registration Number
NCT01230164
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

PEMF: an Adjunct Therapy for Anterior Uveitis

Not Applicable
Completed
Conditions
Anterior Uveitis
Iritis
Interventions
Device: PEMF Placebo
Device: PEMF
First Posted Date
2010-06-30
Last Posted Date
2018-02-28
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Target Recruit Count
18
Registration Number
NCT01154010
Locations
🇺🇸

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath